건강한 한국인 성인 남자에서 성호르몬과 대사증후군과의 연관성 = The association of sex hormones and the metabolic syndrome in apparently healthy Korean male adults

다국어 초록 (Multilingual Abstract)

Background: Recent studies report an association of decreased testosterone levels with type 2 diabetes mellitus, insulin resistance, hyperinsulinemia, dyslipidemia and metabolic syndrome. However, studies on correlations of testosterone with dyslipidemia, insulin resistance and metabolic syndrome in Koreans are scarce. We analyzed the relationship between levels of sex hormones and metabolic syndrome, lipid profiles and insulin resistance in Korean adult males. Methods: A total of 289 males were selected among the participants in a medical health check-up from June to July 2003 at Kangbuk Samsung Hospital Health Promotion Center. Metabolic syndrome was defined according to the Modified National Cholesterol Education Program-Adult Treatment Panel (NCEP-ATP) III. The serum total testosterone level was measured using a radioimmunoassay and sex hormone binding globulin (SHBG) was measured using a radioimmunometric assay. Results: The prevalence of metabolic syndrome was 15.6% and the total testosterone level showed a significant correlation with the levels of high-density lipoprotein cholesterol, fasting insulin, and uric acid even after adjustment for age and body mass index (BMI). Serum SHBG showed a significant correlation with diastolic blood pressure, uric acid, triglyceride, fasting insulin and insulin resistance indices. In logistic regression analysis in which age, drinking history, and smoking status were adjusted, decreased total testosterone and SHBG levels as well as increased estradiol levels showed significant correlations with an increased prevalence of metabolic syndrome. Conclusion: This study shows that decreased total testosterone and SHBG levels and an increased estradiol level were significantly correlated with increased metabolic syndrome prevalence and dyslipidemia in healthy Korean male adults. Further studies are suggested for the association of sex hormone replacement and the changes in the metabolic status. (Korean J Med 73:565-574, 2007)

참고문헌 (Reference)

• 1 Lakka HM, "The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men" 288 : 2709-2716, 2002
• 2 Alexandersen P, "The aging male: testosterone deficiency and testosterone replacement: an up-date" 173 : 157-169, 2004
• 3 Andersson B, "Testosterone concentrations in women and men with NIDDM" 17 : 405-411, 1994
• 4 Laaksonen DE, "Testosterone and sex hormone‐binding globulin predict the metabolic syndrome and diabetes in middle-aged men" 27 : 1036-1041, 2004
• 5 Bhasin S, "Testosterone and atherosclerosis progression in men" 26 : 1929-1931, 2003
• 6 Haffner SM, "Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation" 24 : 56-58, 2000
• 7 Laaksonen DE, "Sex hormones, inflammation and the metabolic syndrome: a population‐based study" 149 : 601-608, 2003
• 8 Reaven GM, "Role of insulin resistance in human disease" 37 : 1595-1607, 1988
• 9 Phillips GB, "Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction" 52 : 784-790, 2003
• 10 Park IS, "Relationship between total testosterone and serum lipid in middle aged men" 22 : 1126-1136, 2001
• 11 Katz A, "Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans" 85 : 2402-2410, 2000
• 12 Birkeland KI, "Level of sex hormone binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes" 76 : 275-278, 1993
• 13 Simon D, "Interrelation between plasma testosterone and plasma insulin in healthy adult men" 35 : 173-177, 1992
• 14 Haffner SM, "Insulin resistance, body fat distribution, and sex hormones in men" 43 : 212-219, 1994
• 15 Nestler JE, "Insulin as an effector of human ovarian and adrenal steroid metabolism" 20 : 807-823, 1991
• 16 Plymate SR, "Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin" 67 : 460-464, 1988
• 17 Schneider G, "Increased estrogen production in obese men" 48 : 633-638, 1979
• 18 Zumoff B, "Hormonal abnormalities in obesity" 723 : 153-160, 1988
• 19 Matthews DR, "Homeostatic model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man" 28 : 412-419, 1985
• 20 Muller M, "Endogenous sex hormones and metabolic syndrome in aging men" 90 : 2618-2623, 2005
• 21 Grundy SM, "Diagnosis and management of the metabolic syndromet" 112 : 2735-2752, 2005
• 22 Vermeulen A, "Decreased androgen levels and obesity in man" 28 : 13-15, 1996
• 23 Assmann G, "Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease" 19 : 1819-1824, 1999
• 24 Couillard C, "Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men" 85 : 1026-1031, 2000
• 25 Simon D, "Association between plasma total testosterone and cardiovascular risk factors in healthy adult men" 82 : 682-685, 1997
• 26 Kapoor D, "Androgens, insulin resistance and vascular disease in men" 63 : 239-250, 2005
• 27 Wu FC, "Androgens and coronary artery disease" 24 : 183-217, 2003
• 28 Marin P, "Androgens and abdominal obesity" 12 : 441-451, 1998
• 29 Gooren LJ, "Androgen replacement therapy: present and future" 64 : 1861-1891, 2004
• 30 Despres JP, "Abdominal obesity as important component of insulin-resistance syndrome" 9 : 452-459, 1993
• 31 Vermeulen A, "A critical evaluation of simple methods of free testosterone in serum" 84 : 3666-3672, 1999
• 32 Curb JD, "A coordinating center in a clinical trial: the Hypertension Detection and Followup Program" 4 : 171-186, 1983